Calidi Biotherapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWSep 25

   Current report

2. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWSep 22

   Current report

3. ROUTINE424B5Calidi Biotherapeutics, Inc.CLDWWSep 17

   Securities offering

4. ROUTINE4Calidi Biotherapeutics, Inc.CLDWWAug 19

   8 insider filings

   James A Schoeneck, insider filing for CLDWW

   Show all 8

   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19
   • 4Insider filing for CLDWWAug 19

   James A Schoeneck, reporting

5. ROUTINESCHEDULE 13G/ACalidi Biotherapeutics, Inc.CLDWWAug 14

   Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

   ARMISTICE CAPITAL, LLC, filed by

6. NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWAug 13

   Quarterly report

7. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWAug 13

   Current report

8. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWJul 31

   Current report

9. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWJul 16

   Current report

10. ROUTINE3Calidi Biotherapeutics, Inc.CLDWWJun 29

    Sanders Corazon (Corsee) D., new insider at CLDWW

    Corazon (Corsee) D. Sanders, reporting

11. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWJun 23

    Current report

12. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWJun 18

    Current report

13. ROUTINEDEFA14ACalidi Biotherapeutics, Inc.CLDWWJun 5

    Additional proxy materials

14. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWMay 29

    Current report

15. ROUTINESCHEDULE 13GCalidi Biotherapeutics, Inc.CLDWWMay 15

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC

    ARMISTICE CAPITAL, LLC, filed by

16. NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWMay 14

    Quarterly report

17. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWMay 14

    Current report

18. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWMay 8

    Current report

19. ROUTINEDEFA14ACalidi Biotherapeutics, Inc.CLDWWApr 29

    Additional proxy materials

20. ROUTINEDEF 14ACalidi Biotherapeutics, Inc.CLDWWApr 29

    Proxy statement

21. ROUTINEPRE 14ACalidi Biotherapeutics, Inc.CLDWWApr 17

    Preliminary proxy statement

22. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWApr 2

    Current report

23. NOTABLESCHEDULE 13DCalidi Biotherapeutics, Inc.CLDWWMar 31

    Ownership stake disclosure by Ognian Anguelov Gavrilov

    Ognian Anguelov Gavrilov, filed by

24. NOTABLE10-KCalidi Biotherapeutics, Inc.CLDWWMar 27

    Annual report

25. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWMar 27

    Current report

26. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWMar 11

    Current report

27. NOTABLESCHEDULE 13DCalidi Biotherapeutics, Inc.CLDWWMar 9

    Ownership stake disclosure by Ognian Anguelov Gavrilov

    Ognian Anguelov Gavrilov, filed by

28. ROUTINES-3MEFCalidi Biotherapeutics, Inc.CLDWWMar 5

    S-3MEF filing

29. ROUTINESCHEDULE 13G/ACalidi Biotherapeutics, Inc.CLDWWFeb 10

    Ownership stake disclosure by Lincoln Alternative Strategies LLC (amended)

    Lincoln Alternative Strategies LLC, filed by

30. ROUTINESCHEDULE 13GCalidi Biotherapeutics, Inc.CLDWWFeb 4

    Ownership stake disclosure by Ognian Anguelov Gavrilov

    Ognian Anguelov Gavrilov, filed by

31. ROUTINE4Calidi Biotherapeutics, Inc.CLDWWDec 16, 2025

    Allan Camaisa, insider filing for CLDWW

    Allan Camaisa, reporting

32. NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWNov 13, 2025

    Quarterly report

33. MAJOR8-KCalidi Biotherapeutics, Inc.CLDWWNov 13, 2025

    Calidi Biotherapeutics, Inc. (CLDWW) filed an 8-K to report the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change could create uncertainty and disrupt the company's ongoing clinical trials and commercialization efforts for its…

34. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWNov 10, 2025

    Current report

35. ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWOct 31, 2025

    Current report

Older filings on EDGAR